| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 07/20/2006 | US20060160887 Medicinal composition |
| 07/20/2006 | US20060160846 Quinoline derivatives |
| 07/20/2006 | US20060160835 Methods and compositions for treatment of central nervous system disorders |
| 07/20/2006 | US20060160798 3-Cyclohexyl-1-methyl-2-pyridin-2-yl-1H-indole-6-carboxylic acid methyl ester; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons |
| 07/20/2006 | US20060160793 Synergistic inhibition of aggregation and inflammation in vessel walls |
| 07/20/2006 | US20060160764 LIMKs as modifiers of p53 pathway and methods of use |
| 07/20/2006 | US20060160750 Compositions of an anticonvulsant and an antipsychotic drug and methods of using the same for affecting weight loss |
| 07/20/2006 | US20060160154 Materials and methods for detection and treatment of breast cancer |
| 07/20/2006 | US20060160146 Method of screening compound affecting amyloid beta production |
| 07/20/2006 | US20060160145 Assay that makes use of the interaction of early pregnancy factor (EPF) or an EPF-related peptide with a human dorsal root receptor (hDRR) or hDRR related receptor; also useful to determine whether the test compound is an agonist or antagonist of hDRRs |
| 07/20/2006 | US20060160079 Methods for the treatment of dementia based on apo e genotype |
| 07/20/2006 | US20060159782 Material for promoting skin basement formation |
| 07/20/2006 | US20060159779 treating Type II diabetes by administering a foodstuff or beverage containing a dried extract of a plant of the genus Hoodia; trigyleride; 3-0-[-.beta.-D-thevetopyranosyl-(1-4)-.beta.-D-cymaropyranosyl-(1-4)-.beta.-D-cymaropyranosyl]-12.beta.-0-tigloyloxy-14-hydroxy-14.beta.-pregn-50-ene-20-one |
| 07/20/2006 | US20060159761 for therapy of allergic and/or inflammatory conditions of the skin and airway passages; desloratadine-pseudoephedrine once-a-day product which produces a release rate profile for pseudoephedrine over an extended period in excess of twelve hours while maintaining delivery of desloratadine |
| 07/20/2006 | US20060159755 Method for producing a controlled release preparation |
| 07/20/2006 | US20060159750 Pharmaceutical dosage form bearing pregnancy-friendly indicia |
| 07/20/2006 | US20060159745 Probiotic and preservative uses of oil-emulsified probiotic encapsulations |
| 07/20/2006 | US20060159726 Method and compositions for potentiating pharmaceuticals with amino acid based medical foods |
| 07/20/2006 | US20060159678 Modulators of cytokine mediated signaling pathways and integrin alphabeta3 receptor antagonists for combination therapy |
| 07/20/2006 | US20060159638 O/W emulsions comprising micronized biologically active agents |
| 07/20/2006 | US20060159629 Perforated; standard particle size; nonaggregating; flowability, dispersibility; lower dosage inhalants |
| 07/20/2006 | US20060158725 Laser projector |
| 07/20/2006 | DE10227938B4 Pharmazeutische Zubereitung, Verfahren zu ihrer Herstellung sowie deren Verwendung A pharmaceutical preparation, processes for their preparation and their use |
| 07/20/2006 | DE102005001989A1 Intravenöse Formulierungen von PDE-Inhibitoren Intravenous formulations of PDE inhibitors |
| 07/20/2006 | CA2594675A1 Therapeutic agent for chronic obstructive pulmonary disease (copd), cystic fibrosis or pulmonary hypertension |
| 07/19/2006 | EP1681290A2 Imidazole derivatives, production method thereof and use thereof |
| 07/19/2006 | EP1680472A2 Compounds for dual photodiagnosis and therapy |
| 07/19/2006 | EP1680411A2 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups |
| 07/19/2006 | EP1680189A2 Combinations of lipid modulating agents and substituted azetidinones and treatments for vascular conditions |
| 07/19/2006 | EP1680143A2 Treatment of arthritic conditions, chronic inflammation or pain |
| 07/19/2006 | EP1680123A1 Use |
| 07/19/2006 | EP1680121A2 Methods and reagents for the treatment of immunoinflammatory disorders |
| 07/19/2006 | EP1680118A1 Combination of a farnesyl transferase inhibitor with an antihormonal agent for the treatment of breast cancer |
| 07/19/2006 | EP1680117A2 Use of a pyrazole derivative for preparing medicaments for the prevention and the treatment of dyslipidemia and illnesses associated with dyslipidemia and/or obesity |
| 07/19/2006 | EP1680115A1 Use of selective opiate receptor modulators in the treatment of neuropathy |
| 07/19/2006 | EP1680114A2 Triazole compounds and uses related thereto |
| 07/19/2006 | EP1680106A1 Combination treatment of obesity involving 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity and lipase inhibitors |
| 07/19/2006 | EP1680102A2 Combinations of a cholesterol biosynthesis inhibitor and a soluble fiber for the treatment of conditions associated with elevated cholesterol levels |
| 07/19/2006 | EP1680099A2 Hdl-boosting combination therapy complexes |
| 07/19/2006 | EP1680094A1 Controlled release formulations of opioid and nonopioid analgesics |
| 07/19/2006 | EP1680093A1 Oral formulation of lipid soluble thiamine, lipoic acid, creatine derivative, and l-arginine alpha-ketoglutarate |
| 07/19/2006 | EP1680091A1 A solid dosage form comprising a fibrate |
| 07/19/2006 | EP1680089A1 Composition comprising biodegradable hydrating ceramics for controlled drug delivery |
| 07/19/2006 | EP1680086A2 A solid dosage form comprising a fibrate and a statin |
| 07/19/2006 | EP1680084A2 A multiple route medication for the treatment of rhinitis and asthma |
| 07/19/2006 | EP1680073A2 Compounds and method for treating cancer |
| 07/19/2006 | EP1679962A1 Zeolite molecular sieves for the removal of toxins |
| 07/19/2006 | EP1463812A4 Degp protease: cleavage site identification and proteolysis of a natural target in e. coli |
| 07/19/2006 | EP1395273B1 Targeted delivery of drugs for the treatment of viral infections |
| 07/19/2006 | EP1393277B1 USE OF NF-Kappa-B INHIBITORS TO TREAT DRY EYE DISORDERS |
| 07/19/2006 | EP1276880B1 Polymorphisms in the human cyp2d6 gene promoter region and their use in diagnostic and therapeutic applications |
| 07/19/2006 | EP1223930B1 Treatment of dyskinesia |
| 07/19/2006 | EP1121109B8 Biphasic tramadol preparation |
| 07/19/2006 | EP1082967B1 Prevention and treatment of autoimmune demyelinating diseases by Fas-antagonists |
| 07/19/2006 | EP0996447B1 Combination therapy for modulating the human sexual response |
| 07/19/2006 | EP0898580B1 Methods and means for inhibition of cdk4 activity |
| 07/19/2006 | EP0835447B1 Novel peptides and compositions which modulate apoptosis |
| 07/19/2006 | CN1805758A Nucleotide and cellular vaccine composition |
| 07/19/2006 | CN1805756A Vav inhibition in graft rejection. |
| 07/19/2006 | CN1805739A Anti-inflammatory analgesic adhesive patch |
| 07/19/2006 | CN1805738A Extended-release tablets of metformin |
| 07/19/2006 | CN1803837A Neurotrophic growth factor |
| 07/19/2006 | CN1803795A Substituted piperidine compounds for use as h3 histamine receptor antagonists |
| 07/19/2006 | CN1803193A Use of stroma stem cell derived from bone marrow in preparing formulation for treating hypoxic ischemic cerebral palsy |
| 07/19/2006 | CN1803192A Use of stroma stem cell derived from bone marrow in preparing formulation for treating hepatic fibrosis |
| 07/19/2006 | CN1803191A Assistant for high-intensity focusing ultrasonic therapy and its screening method |
| 07/19/2006 | CN1803189A Use of botulinum toxin for the treatment of unstable bladder |
| 07/19/2006 | CN1803144A Pharmaceutical composition containing clofibrate compound and B family vitamin |
| 07/19/2006 | CN1264858C Angiogenesis-inhibitory tripeptides, compositions and their methods of use |
| 07/19/2006 | CN1264821C Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof |
| 07/19/2006 | CN1264574C Oral preparations |
| 07/19/2006 | CN1264499C Cosmtics treatment using novel retinoid |
| 07/18/2006 | US7078515 Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalized epilepsy with febrile seizures plus |
| 07/18/2006 | US7078510 Robust, inducible cardiac preferred expression system for transgenesis |
| 07/18/2006 | US7078506 Canineil-4nucleic acid molecules and uses thereof |
| 07/18/2006 | US7078487 Polynucleotides encoding the zebrafish PTH1R (parthyroid hormone like protein) receptor |
| 07/18/2006 | US7078431 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat VCAM-1 mediated disorders |
| 07/18/2006 | US7078421 Substituted phenylacetic acids |
| 07/18/2006 | US7078416 Polypeptides |
| 07/18/2006 | US7078403 Antiviral agents |
| 07/18/2006 | US7078399 Antiulcer agents; antiinflammatory agents; therapy for ear infections |
| 07/18/2006 | US7078398 Compositions and methods for treating or preventing convulsions or seizures |
| 07/18/2006 | US7078397 Comprises thiadiazolidinedione-based insulin sensitizers (troglitazone); peroxisome proliferator-activated receptors |
| 07/18/2006 | US7078381 Method of regulating glucose metabolism, and reagents related thereto |
| 07/18/2006 | US7078377 Compositions and methods for treatment of staphylococcal infection while suppressing formation of antibiotic-resistant strains |
| 07/18/2006 | US7078217 Aggrecanase molecules |
| 07/18/2006 | US7078206 for drug screening enzyme inhibitors; by isolating DNA from a patient, amplifying exons by polymerase chain reaction (PCR) and detecting the presence of DNA sequence variation; genetic engineering |
| 07/18/2006 | US7078196 Genetic engineering ; induction post-transcriptional gene blocking |
| 07/18/2006 | US7078178 Identifying modulators of transmembrane calcium transfer; for treating bone, cancer and blood disorders |
| 07/18/2006 | US7078177 Identifying modulators of oncogene receptor binding activity for treating pain, neuropathic and inflammatory, learning and memory, anxiety and cardiovascular disorders |
| 07/18/2006 | US7078173 Assays and therapies for latent viral infection |
| 07/18/2006 | US7078064 Antioxidation; reducing oxidative stresses; oral administering of mixture of glycyrrhzin, vitamin c, silymarin, lipoic acid and tocopherol |
| 07/18/2006 | US7078057 Heating with carrier; mixtur eof fine and coarse particle sizes |
| 07/18/2006 | US7078050 White cream bacteriostats, fungicide as vehicle for drug; receptivity |
| 07/18/2006 | US7078048 A topical formulation for treating rosacea ( a facial dermatitis ) contains a combination of: an antimicrobial and at least one of non-retinoid inhibitor of one of nuclear factor-k-beta, AP-1 protein, matrix metalloproteinases, CD14 |
| 07/18/2006 | US7078045 Pharmaceutical composition for treatment and prevention of liver fibrosis and cirrhosis |
| 07/18/2006 | US7078040 Administering to animal or man of at least one type of xanthophyll in an amount inhibiting the expression of inflammatory cytokines and chemokines in animal or man |
| 07/18/2006 | US7078020 Heating antipsychotic drug to vaporize; cooling to form condensation aerosol; kit for dispensing thin coating |
| 07/18/2006 | US7078019 Heating a drug ester to vaporize; cooling to form condensation aerosol; drug delivery kit for dispensing thin coatings |
| 07/18/2006 | US7078018 Aerosol therapy; heating, vaporization, cooling, condensation; analgesics; alcoholism |